Zobrazeno 1 - 10
of 78
pro vyhledávání: '"E. V. Filippov"'
Autor:
E. V. Filippov
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 84-91 (2021)
Over the past few decades, there have been significant changes in approaches to the management of patients with pulmonary arterial hypertension (PAH). From the moment when the classification of this disease was first published, new diagnostic capabil
Externí odkaz:
https://doaj.org/article/b4aec7fce07f4f2f97fdcd62aa58b7fb
Autor:
I. E. Chazova, T. V. Martynyuk, Z. S. Valieva, V. A. Azizov, R. S. Akchurin, A. A. Ansheles, O. Ya. Vasiltseva, T. N. Veselova, A. S. Galyavich, S. V. Gorbachevsky, N. M. Danilov, A. G. Edemskiy, P. A. Zelveyan, I. V. Lazareva, Yu. G. Matchin, K. V. Mershin, M. A. Mukarov, S. N. Nakonechnikov, M. A. Saidova, A. Sh. Sarybaev, V. B. Sergienko, O. V. Stukalova, E. V. Filippov, A. M. Chernyavsky, M. A. Chernyavsky, S. V. Shalaev, A. A. Shmalts
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 6-43 (2021)
Disclaimer The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event
Externí odkaz:
https://doaj.org/article/a13d1258009e48e0a0b46a800b1474fe
Autor:
E. V. Filippov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 6, Pp 1009-1016 (2020)
The article is devoted to topical issues of management of patients with pulmonary arterial hypertension and strategies for switching to riociguat therapy in patients with insufficient clinical response against the background of phosphodiesterase type
Externí odkaz:
https://doaj.org/article/2c280867ef3148439367cee2b7b4ed12
Autor:
L. I. Folomeeva, E. V. Filippov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 4, Pp 536-541 (2020)
Supraventricular arrhythmias, including atrial fibrillation (AF), are a current problem for patients in the older age group due to the possibility of lifethreatening complications. Elderly patients have pre-conditions for the development of supravent
Externí odkaz:
https://doaj.org/article/01191f0523fc437a89c0ca0f1d3dbb89
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 6, Pp 795-801 (2020)
Aim. To study the effectiveness and benefits of blood pressure (BP) remote monitoring in outpatients with hypertension.Material and methods. The study included 100 patients with a verified diagnosis of hypertension, who didn’t achieve target BP pre
Externí odkaz:
https://doaj.org/article/88d9c5325cd742a18417503ba4230562
Autor:
L. I. Kudryavtseva, E. V. Filippov
Publikováno v:
Медицинский совет, Vol 0, Iss 16, Pp 68-71 (2019)
Given the significant increase in the frequency of atrial fibrillation (AF) in elderly and senile patients with confirmed coronary heart disease (CHD), the study of the relationship between the polymorphisms responsible for the functioning of the ren
Externí odkaz:
https://doaj.org/article/b59f41f685e84c68a7ab127de485a412
Autor:
E. V. Filippov, K. A. Moseychuk
Publikováno v:
Медицинский совет, Vol 0, Iss 16, Pp 28-33 (2019)
Coronary artery disease (CAD) can manifest as a classic chest pain, or atypical angina. At the same time, the prevalence of CAD in a group of male patients with atypical angina over the age of 60 can reach 59--78%. It should be noted that the clinic
Externí odkaz:
https://doaj.org/article/fade6612b948407eb10fcc0e056c2d75
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 6, Pp 131-134 (2019)
Despite the decline in cardiovascular mortality in Russia over the past 15 years, it remains relevant to study the possibilities of its further reducing. And preventive measures of risk factors reducing play the main role. However, before developing
Externí odkaz:
https://doaj.org/article/865fb95b88b64f3fa29d30142974e5ee
Autor:
E. V. Filippov, A. N. Vorobyev, N. V. Dobrynina, L. A. Zotova, E. V. Lygina, N. N. Nikulina, S. V. Seleznev, S. S. Yakushin
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 6, Pp 42-48 (2019)
Aim. To assess the incidence of adverse outcomes and the role of main risk factors in their development.Material and methods. Prospective, long-term study was conducted with observation period of 36 months. The sample in the MERIDIAN-RO study was for
Externí odkaz:
https://doaj.org/article/e8fe747917804cd388b0990ecf4cce59
Autor:
L. I. Kudryavtseva, E. V. Filippov
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 44-52 (2019)
Over the past 20 years, the burden of atrial fibrillation (AF) has increased. AF is associated with increased risk of death, ischemic stroke and disability, hospitalization rates, and reduced quality of life. Treatment for this pathology is based on
Externí odkaz:
https://doaj.org/article/8f8dadca39b041fc907cd4170716af55